Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-08-08
2010-10-05
Weddington, Kevin (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S220000, C514S592000, C514S635000, C514S866000
Reexamination Certificate
active
07807663
ABSTRACT:
A pharmaceutical composition for preventing and/or treating diabetes, diabetic complication, hyperinsulinemia, disorders of glucose metabolism or obesity, comprising a combination of the following compound, analogues or pharmaceutically acceptable salts thereof with a hypoglycemic agent.
REFERENCES:
patent: 2961377 (1960-11-01), Shapiro et al.
patent: 3174901 (1965-03-01), Sterne
patent: 3501495 (1970-03-01), Laszlo et al.
patent: 4062950 (1977-12-01), Frommer et al.
patent: 2004/0048847 (2004-03-01), Iino et al.
patent: WO 02/44180 (2002-08-01), None
patent: WO 2005/042536 (2005-05-01), None
Windholz et al., The Merck Index, Tenth Edition, 1983, p. 3, abstract No. 11 and p. 204, abstract No. 1445.
Leibowitz et al., “A novel insulin secretagogue is a phosphodiesterase inhibitor”, Diabetes, vol. 44, issue 1, pp. 67-74 (abstract).
U.S. Appl. No. 11/486,213, filed Jul. 14, 2006, Hirama, et al.
M.D., Mashkovsky, “Medicaments”, Moscow Medicine, 1985, part 1, pp. 551-552, 562-563 (with English translation).
M. Riddle, “Combining Sulfonylureas and Other Oral Agents”, The American Journal of Medicine, vol. 108, 6A, Apr. 17, 2000, pp. 15S-22S.
J. Buse, “Combining Insulin and Oral Agents”, The American Journal of Medicine, vol. 108, 6A, Apr. 17, 2000, pp. 23S-32S.
H. Gin, et al., “Oral Anti Diabetic Polychemotherapy in Type 2 Diabetes Mellitus”, Diabetes Metab, vol. 28, No. 5, 2002, pp. 350-353.
M. Okubo, et al., “Pharmacologic Profile of Oral Antidiabetic Agents”, Nippon Rinsho, 60 Suppl, 9, pp. 310-316 w/attached English excerpt, (2002).
U.S. Appl. No. 11/398,675, filed Apr. 6, 2006, Iino, et al.
U.S. Appl. No. 11/414,499, filed May 1, 2006, Hirama, et al.
Iino Yukio
Ikenoue Takao
Kageyama Yoko
Kondo Nobuo
Ajinomoto Co. Inc.
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
Weddington Kevin
LandOfFree
Therapeutic agents for diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic agents for diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agents for diabetes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4207642